Cornercap Investment Counsel Inc. Sells 28,302 Shares of Avanos Medical, Inc. (NYSE:AVNS)

Cornercap Investment Counsel Inc. lessened its stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 52.3% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 25,769 shares of the company's stock after selling 28,302 shares during the quarter. Cornercap Investment Counsel Inc. owned about 0.06% of Avanos Medical worth $619,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. KBC Group NV raised its position in shares of Avanos Medical by 63.0% in the 3rd quarter. KBC Group NV now owns 2,833 shares of the company's stock valued at $68,000 after buying an additional 1,095 shares in the last quarter. Canada Pension Plan Investment Board acquired a new position in Avanos Medical during the second quarter valued at approximately $70,000. EntryPoint Capital LLC lifted its stake in Avanos Medical by 97.6% during the first quarter. EntryPoint Capital LLC now owns 5,601 shares of the company's stock worth $112,000 after purchasing an additional 2,766 shares during the last quarter. XTX Topco Ltd acquired a new stake in shares of Avanos Medical in the 2nd quarter valued at $202,000. Finally, Magnetar Financial LLC bought a new position in shares of Avanos Medical in the 2nd quarter valued at $248,000. Institutional investors own 95.17% of the company's stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded Avanos Medical from a "strong-buy" rating to a "buy" rating in a research report on Sunday, November 3rd.

Avanos Medical Price Performance

Shares of Avanos Medical stock traded down $0.47 during midday trading on Friday, hitting $18.68. 227,214 shares of the company traded hands, compared to its average volume of 241,716. The firm's fifty day moving average price is $22.30 and its 200-day moving average price is $21.59. The stock has a market cap of $858.53 million, a price-to-earnings ratio of 54.94 and a beta of 0.92. Avanos Medical, Inc. has a 12 month low of $17.39 and a 12 month high of $25.36. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.